English

Ortho Clinical Diagnostics Holdings plc

EDGAR

OCDX Quarterly report (10-Q) · filed 2022-05-10

8 filing records in this dataset, filed from 2021-01-04 to 2022-05-10. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

500 million USD

2022-04-03 · USD

Exact inputs and evidence

Revenue: 500100000 USD Source

Operating margin

9.42%

2022-04-03 · %

Exact inputs and evidence

Operating Income: 47100000 USD Source
Revenue: 500100000 USD Source

Operating cash flow

-4 million USD

2022-04-03 · USD

Exact inputs and evidence

Operating Cash Flow: -4000000 USD Source

Free cash flow

-31 million USD

2022-04-03 · USD

Exact inputs and evidence

Operating Cash Flow: -4000000 USD Source
Capital Expenditure: 27000000 USD Source

Cash and cash equivalents: 281 million USD 2022-04-03 Source
Exact value

281100000 USD
Long-term debt including current maturities: 2.28 billion USD 2022-01-02
Exact inputs and evidence

2276900000 USD

Long-term debt including current maturities: 2276900000 USD Source
Shares outstanding: 238 million shares 2022-04-03 Source
Exact value

237612459 shares

Reported share-count change

1.18% · 2.77 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

234843052 shares · 2021-04-04· Source
237612459 shares · 2022-04-03· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

2.04 billion USD

2021-04-05 – 2022-04-03

Exact inputs and evidence

Revenue: 492500000 USD · 2021-04-05 – 2021-07-04 Source
Revenue: 522500000 USD · 2021-07-05 – 2021-10-03 Source
Revenue: 2042800000 USD · 2021-01-04 – 2022-01-02 Source
Revenue: 1521800000 USD · 2021-01-04 – 2021-10-03 Source
Revenue: 500100000 USD · 2022-01-03 – 2022-04-03 Source

Net income

-400 thousand USD

2021-04-05 – 2022-04-03

Exact inputs and evidence

Net income: -20000000 USD · 2021-04-05 – 2021-07-04 Source
Net income: 14700000 USD · 2021-07-05 – 2021-10-03 Source
Net income: -54300000 USD · 2021-01-04 – 2022-01-02 Source
Net income: -44400000 USD · 2021-01-04 – 2021-10-03 Source
Net income: 14800000 USD · 2022-01-03 – 2022-04-03 Source

Operating cash flow

293 million USD

2021-04-05 – 2022-04-03

Exact inputs and evidence

Operating cash flow: 122800000 USD · 2021-01-04 – 2021-07-04 Source
Operating cash flow: -9900000 USD · 2021-01-04 – 2021-04-04 Source
Operating cash flow: 188200000 USD · 2021-01-04 – 2021-10-03 Source
Operating cash flow: 122800000 USD · 2021-01-04 – 2021-07-04 Source
Operating cash flow: 286600000 USD · 2021-01-04 – 2022-01-02 Source
Operating cash flow: 188200000 USD · 2021-01-04 – 2021-10-03 Source
Operating cash flow: -4000000 USD · 2022-01-03 – 2022-04-03 Source

Capital expenditure

72 million USD

2021-04-05 – 2022-04-03

Exact inputs and evidence

Capital expenditure: 19600000 USD · 2021-01-04 – 2021-07-04 Source
Capital expenditure: 13400000 USD · 2021-01-04 – 2021-04-04 Source
Capital expenditure: 27200000 USD · 2021-01-04 – 2021-10-03 Source
Capital expenditure: 19600000 USD · 2021-01-04 – 2021-07-04 Source
Capital expenditure: 58400000 USD · 2021-01-04 – 2022-01-02 Source
Capital expenditure: 27200000 USD · 2021-01-04 – 2021-10-03 Source
Capital expenditure: 27000000 USD · 2022-01-03 – 2022-04-03 Source

Free cash flow

221 million USD

2021-04-05 – 2022-04-03

Exact inputs and evidence

Operating cash flow: 122800000 USD · 2021-01-04 – 2021-07-04 Source
Operating cash flow: -9900000 USD · 2021-01-04 – 2021-04-04 Source
Operating cash flow: 188200000 USD · 2021-01-04 – 2021-10-03 Source
Operating cash flow: 122800000 USD · 2021-01-04 – 2021-07-04 Source
Operating cash flow: 286600000 USD · 2021-01-04 – 2022-01-02 Source
Operating cash flow: 188200000 USD · 2021-01-04 – 2021-10-03 Source
Operating cash flow: -4000000 USD · 2022-01-03 – 2022-04-03 Source
Capital expenditure: 19600000 USD · 2021-01-04 – 2021-07-04 Source
Capital expenditure: 13400000 USD · 2021-01-04 – 2021-04-04 Source
Capital expenditure: 27200000 USD · 2021-01-04 – 2021-10-03 Source
Capital expenditure: 19600000 USD · 2021-01-04 – 2021-07-04 Source
Capital expenditure: 58400000 USD · 2021-01-04 – 2022-01-02 Source
Capital expenditure: 27200000 USD · 2021-01-04 – 2021-10-03 Source
Capital expenditure: 27000000 USD · 2022-01-03 – 2022-04-03 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2022-05-10.

Financial data available through: 2022-01-02.

Coverage by financial measure

Revenue: 3 of 11 periods available· newest 2022-01-02
Operating income: 3 of 11 periods available· newest 2022-01-02
Net income: 3 of 11 periods available· newest 2022-01-02
Operating cash flow: 3 of 11 periods available· newest 2022-01-02
Capital expenditure: 3 of 11 periods available· newest 2022-01-02
Total assets: 2 of 11 periods available· newest 2022-01-02
Total liabilities: 2 of 11 periods available· newest 2022-01-02
Current assets: 2 of 11 periods available· newest 2022-01-02
Current liabilities: 2 of 11 periods available· newest 2022-01-02
Cash and cash equivalents: 3 of 11 periods available· newest 2022-01-02
Long-term debt including current maturities: 1 of 11 periods available· newest 2022-01-02
Shares outstanding: 2 of 11 periods available· newest 2022-01-02

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+15.7%

Prior period

USD 1.77 billion

2019-12-30 – 2021-01-03
Current period

USD 2.04 billion

2021-01-04 – 2022-01-02

Exact inputs and evidence

2042800000 − 1766200000 = 276600000 USD

1766200000 USD · 2019-12-30 – 2021-01-03
Inspect prior input Prior source
2042800000 USD · 2021-01-04 – 2022-01-02
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Ortho Clinical Diagnostics Holdings plc · 2022-01-02 Ortho Clinical Diagnostics Holdings plc (edgar:1828443) Year-over-year change in Revenue: 276600000 USD Concept: fundies:Revenue Period: 2021-01-04 to 2022-01-02 Values: Latest reported Published: 2026-11-08T17:47:47Z Snapshot: 4069925ec9873ba457396077fee9c8be77e9d30342e3266a3eacf47ab5ab0a79 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1828443?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 2042800000 USD (2021-01-04 to 2022-01-02) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1828443/000095017022003035/ocdx-20220102.htm#6217526 Filing: 000095017022003035 Input fundies:Revenue: 1766200000 USD (2019-12-30 to 2021-01-03) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1828443/000095017022003035/ocdx-20220102.htm#6219464 Filing: 000095017022003035
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 157.6 million

Prior period

−USD 211.9 million

2019-12-30 – 2021-01-03
Current period

−USD 54.3 million

2021-01-04 – 2022-01-02

Exact inputs and evidence

-54300000 − -211900000 = 157600000 USD

-211900000 USD · 2019-12-30 – 2021-01-03
Inspect prior input Prior source
-54300000 USD · 2021-01-04 – 2022-01-02
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Ortho Clinical Diagnostics Holdings plc · 2022-01-02 Ortho Clinical Diagnostics Holdings plc (edgar:1828443) Year-over-year change in Net income: 157600000 USD Concept: fundies:NetIncome Period: 2021-01-04 to 2022-01-02 Values: Latest reported Published: 2026-11-08T17:47:47Z Snapshot: 4069925ec9873ba457396077fee9c8be77e9d30342e3266a3eacf47ab5ab0a79 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1828443?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -54300000 USD (2021-01-04 to 2022-01-02) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1828443/000095017022003035/ocdx-20220102.htm#3416483 Filing: 000095017022003035 Input fundies:NetIncome: -211900000 USD (2019-12-30 to 2021-01-03) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1828443/000095017022003035/ocdx-20220102.htm#2862639 Filing: 000095017022003035
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+521.7%

Prior period

USD 46.1 million

2019-12-30 – 2021-01-03
Current period

USD 286.6 million

2021-01-04 – 2022-01-02

Exact inputs and evidence

286600000 − 46100000 = 240500000 USD

46100000 USD · 2019-12-30 – 2021-01-03
Inspect prior input Prior source
286600000 USD · 2021-01-04 – 2022-01-02
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Ortho Clinical Diagnostics Holdings plc · 2022-01-02 Ortho Clinical Diagnostics Holdings plc (edgar:1828443) Year-over-year change in Operating cash flow: 240500000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-04 to 2022-01-02 Values: Latest reported Published: 2026-11-08T17:47:47Z Snapshot: 4069925ec9873ba457396077fee9c8be77e9d30342e3266a3eacf47ab5ab0a79 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1828443?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 286600000 USD (2021-01-04 to 2022-01-02) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1828443/000095017022003035/ocdx-20220102.htm#3417426 Filing: 000095017022003035 Input fundies:OperatingCashFlow: 46100000 USD (2019-12-30 to 2021-01-03) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1828443/000095017022003035/ocdx-20220102.htm#3238601 Filing: 000095017022003035
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+32.4%

Prior period

USD 44.1 million

2019-12-30 – 2021-01-03
Current period

USD 58.4 million

2021-01-04 – 2022-01-02

Exact inputs and evidence

58400000 − 44100000 = 14300000 USD

44100000 USD · 2019-12-30 – 2021-01-03
Inspect prior input Prior source
58400000 USD · 2021-01-04 – 2022-01-02
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Ortho Clinical Diagnostics Holdings plc · 2022-01-02 Ortho Clinical Diagnostics Holdings plc (edgar:1828443) Year-over-year change in Capital expenditure: 14300000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-04 to 2022-01-02 Values: Latest reported Published: 2026-11-08T17:47:47Z Snapshot: 4069925ec9873ba457396077fee9c8be77e9d30342e3266a3eacf47ab5ab0a79 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1828443?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 58400000 USD (2021-01-04 to 2022-01-02) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1828443/000095017022003035/ocdx-20220102.htm#3246718 Filing: 000095017022003035 Input fundies:CapitalExpenditure: 44100000 USD (2019-12-30 to 2021-01-03) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1828443/000095017022003035/ocdx-20220102.htm#3248716 Filing: 000095017022003035
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2022 2021-01-04 – 2022-01-02

Revenue USD 2.04 billion 100% of revenue
Cost of revenue USD 1.01 billion 49% of revenue
Operating expenses USD 681.2 million 33% of revenue
Other operating costs Derived USD 180.9 million 8.9% of revenue
Operating income USD 173.9 million 8.5% of revenue
Tax, interest and other Derived USD 228.2 million 11% of revenue
Net income −USD 54.3 million −2.7% of revenue

Cash

Operating cash flow USD 286.6 million 14% of revenue
Capital expenditure USD 58.4 million 2.9% of revenue
Free cash flow Derived USD 228.2 million 11% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2020 Net loss: net income was −8.7% of revenue.
2021 Net loss: net income was −12% of revenue.
2022 Net loss: net income was −2.7% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2020 2018-12-31 – 2019-12-29	1801500000	1716000000 Derived	85500000	242400000 Derived	-156900000	76800000 Derived	Source 2018-12-31 – 2019-12-29: 1801500000 USD Inspect Revenue Open source 2018-12-31 – 2019-12-29: 85500000 USD Inspect Operating Income Open source 2018-12-31 – 2019-12-29: -156900000 USD Inspect Net Income Open source 2018-12-31 – 2019-12-29: 143000000 USD Inspect Operating Cash Flow Open source 2018-12-31 – 2019-12-29: 66200000 USD Inspect Capital Expenditure Open source
2021 2019-12-30 – 2021-01-03	1766200000	1677900000 Derived	88300000	300200000 Derived	-211900000	2000000 Derived	Source 2019-12-30 – 2021-01-03: 1766200000 USD Inspect Revenue Open source 2019-12-30 – 2021-01-03: 88300000 USD Inspect Operating Income Open source 2019-12-30 – 2021-01-03: -211900000 USD Inspect Net Income Open source 2019-12-30 – 2021-01-03: 46100000 USD Inspect Operating Cash Flow Open source 2019-12-30 – 2021-01-03: 44100000 USD Inspect Capital Expenditure Open source
2022 2021-01-04 – 2022-01-02	2042800000	1868900000 Derived	173900000	228200000 Derived	-54300000	228200000 Derived	Source 2021-01-04 – 2022-01-02: 2042800000 USD Inspect Revenue Open source 2021-01-04 – 2022-01-02: 173900000 USD Inspect Operating Income Open source 2021-01-04 – 2022-01-02: -54300000 USD Inspect Net Income Open source 2021-01-04 – 2022-01-02: 286600000 USD Inspect Operating Cash Flow Open source 2021-01-04 – 2022-01-02: 58400000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 2B 2022

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20202019-12-29	Revenue	1801500000	Revenue: 1801500000 Open source
20212021-01-03	Revenue	1766200000	Revenue: 1766200000 Open source
20222022-01-02	Revenue	2042800000	Revenue: 2042800000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

15.7% 2022

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20202019-12-29	Year over year	No prior comparable period	Revenue: 1801500000 Open source
20212021-01-03	Year over year	-2%	Revenue: 1766200000 Open source Revenue: 1801500000 Open source
20222022-01-02	Year over year	15.7%	Revenue: 2042800000 Open source Revenue: 1766200000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 8.5% 2022

Net margin -2.7% 2022

Free cash flow margin 11.2% 2022

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20202019-12-29	Operating margin	4.7%	Operating Income: 85500000 Open source Revenue: 1801500000 Open source
20212021-01-03	Operating margin	5%	Operating Income: 88300000 Open source Revenue: 1766200000 Open source
20222022-01-02	Operating margin	8.5%	Operating Income: 173900000 Open source Revenue: 2042800000 Open source
20202019-12-29	Net margin	-8.7%	Net Income: -156900000 Open source Revenue: 1801500000 Open source
20212021-01-03	Net margin	-12%	Net Income: -211900000 Open source Revenue: 1766200000 Open source
20222022-01-02	Net margin	-2.7%	Net Income: -54300000 Open source Revenue: 2042800000 Open source
20202019-12-29	Free cash flow margin	4.3%	Revenue: 1801500000 Open source Operating Cash Flow: 143000000 Open source Capital Expenditure: 66200000 Open source
20212021-01-03	Free cash flow margin	0.1%	Revenue: 1766200000 Open source Operating Cash Flow: 46100000 Open source Capital Expenditure: 44100000 Open source
20222022-01-02	Free cash flow margin	11.2%	Revenue: 2042800000 Open source Operating Cash Flow: 286600000 Open source Capital Expenditure: 58400000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 286.6M 2022

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20202019-12-29	Operating cash flow	143000000	Operating Cash Flow: 143000000 Open source
20212021-01-03	Operating cash flow	46100000	Operating Cash Flow: 46100000 Open source
20222022-01-02	Operating cash flow	286600000	Operating Cash Flow: 286600000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 228.2M 2022

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20202019-12-29	Free cash flow	76800000	Operating Cash Flow: 143000000 Open source Capital Expenditure: 66200000 Open source
20212021-01-03	Free cash flow	2000000	Operating Cash Flow: 46100000 Open source Capital Expenditure: 44100000 Open source
20222022-01-02	Free cash flow	228200000	Operating Cash Flow: 286600000 Open source Capital Expenditure: 58400000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

87.8% 2022

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2019-12-29	Liabilities / assets	Not reported	No source recorded
20212021-01-03	Liabilities / assets	129.7%	Total Liabilities: 4412300000 Open source Total Assets: 3401500000 Open source
20222022-01-02	Liabilities / assets	87.8%	Total Liabilities: 2953300000 Open source Total Assets: 3363800000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.75× 2022

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2019-12-29	Current assets / current liabilities	Not reported	No source recorded
20212021-01-03	Current assets / current liabilities	1.37×	Current Assets: 857200000 Open source Current Liabilities: 626400000 Open source
20222022-01-02	Current assets / current liabilities	1.75×	Current Assets: 1011700000 Open source Current Liabilities: 578500000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2020 2018-12-31 – 2019-12-29	−USD 156.9 million Exact value Exact value: -156900000 USD 2018-12-31 – 2019-12-29: -156900000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Ortho Clinical Diagnostics Holdings plc · 2019-12-29 Ortho Clinical Diagnostics Holdings plc (edgar:1828443) Net Income: -156900000 USD Concept: fundies:NetIncome Period: 2018-12-31 to 2019-12-29 Values: Latest reported Published: 2026-11-08T17:47:47Z Snapshot: 4069925ec9873ba457396077fee9c8be77e9d30342e3266a3eacf47ab5ab0a79 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1828443/explain?concept=fundies%3ANetIncome&period=2019-12-29&surface=latest&period_type=duration&start=2018-12-31&unit=USD&dimensions= Input fundies:NetIncome: -156900000 USD (2018-12-31 to 2019-12-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1828443/000095017022003035/ocdx-20220102.htm#2712067 Filing: 000095017022003035 The citation records this snapshot. The page link may show a newer release later.	USD 143 million Exact value Exact value: 143000000 USD 2018-12-31 – 2019-12-29: 143000000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Ortho Clinical Diagnostics Holdings plc · 2019-12-29 Ortho Clinical Diagnostics Holdings plc (edgar:1828443) Operating Cash Flow: 143000000 USD Concept: fundies:OperatingCashFlow Period: 2018-12-31 to 2019-12-29 Values: Latest reported Published: 2026-11-08T17:47:47Z Snapshot: 4069925ec9873ba457396077fee9c8be77e9d30342e3266a3eacf47ab5ab0a79 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1828443/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-29&surface=latest&period_type=duration&start=2018-12-31&unit=USD&dimensions= Input fundies:OperatingCashFlow: 143000000 USD (2018-12-31 to 2019-12-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1828443/000095017022003035/ocdx-20220102.htm#3240510 Filing: 000095017022003035 The citation records this snapshot. The page link may show a newer release later.	USD 66.2 million Exact value Exact value: 66200000 USD 2018-12-31 – 2019-12-29: 66200000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Ortho Clinical Diagnostics Holdings plc · 2019-12-29 Ortho Clinical Diagnostics Holdings plc (edgar:1828443) Capital Expenditure: 66200000 USD Concept: fundies:CapitalExpenditure Period: 2018-12-31 to 2019-12-29 Values: Latest reported Published: 2026-11-08T17:47:47Z Snapshot: 4069925ec9873ba457396077fee9c8be77e9d30342e3266a3eacf47ab5ab0a79 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1828443/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-29&surface=latest&period_type=duration&start=2018-12-31&unit=USD&dimensions= Input fundies:CapitalExpenditure: 66200000 USD (2018-12-31 to 2019-12-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1828443/000095017022003035/ocdx-20220102.htm#3250714 Filing: 000095017022003035 The citation records this snapshot. The page link may show a newer release later.	USD 76.8 million Calculation and evidence 143000000 − 66200000 USD Exact free cash flow: 76800000 USD 2018-12-31 – 2019-12-29: 143000000 USD · Inspect Operating Cash Flow · Source 2018-12-31 – 2019-12-29: 66200000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Ortho Clinical Diagnostics Holdings plc · 2019-12-29 Ortho Clinical Diagnostics Holdings plc (edgar:1828443) Free cash flow: 76800000 USD Concept: free-cash-flow Period: 2018-12-31 to 2019-12-29 Values: Latest reported Published: 2026-11-08T17:47:47Z Snapshot: 4069925ec9873ba457396077fee9c8be77e9d30342e3266a3eacf47ab5ab0a79 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1828443?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 143000000 USD (2018-12-31 to 2019-12-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1828443/000095017022003035/ocdx-20220102.htm#3240510 Filing: 000095017022003035 Input fundies:CapitalExpenditure: 66200000 USD (2018-12-31 to 2019-12-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1828443/000095017022003035/ocdx-20220102.htm#3250714 Filing: 000095017022003035 The citation records this snapshot. The page link may show a newer release later.
2021 2019-12-30 – 2021-01-03	−USD 211.9 million Exact value Exact value: -211900000 USD 2019-12-30 – 2021-01-03: -211900000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Ortho Clinical Diagnostics Holdings plc · 2021-01-03 Ortho Clinical Diagnostics Holdings plc (edgar:1828443) Net Income: -211900000 USD Concept: fundies:NetIncome Period: 2019-12-30 to 2021-01-03 Values: Latest reported Published: 2026-11-08T17:47:47Z Snapshot: 4069925ec9873ba457396077fee9c8be77e9d30342e3266a3eacf47ab5ab0a79 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1828443/explain?concept=fundies%3ANetIncome&period=2021-01-03&surface=latest&period_type=duration&start=2019-12-30&unit=USD&dimensions= Input fundies:NetIncome: -211900000 USD (2019-12-30 to 2021-01-03) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1828443/000095017022003035/ocdx-20220102.htm#2862639 Filing: 000095017022003035 The citation records this snapshot. The page link may show a newer release later.	USD 46.1 million Exact value Exact value: 46100000 USD 2019-12-30 – 2021-01-03: 46100000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Ortho Clinical Diagnostics Holdings plc · 2021-01-03 Ortho Clinical Diagnostics Holdings plc (edgar:1828443) Operating Cash Flow: 46100000 USD Concept: fundies:OperatingCashFlow Period: 2019-12-30 to 2021-01-03 Values: Latest reported Published: 2026-11-08T17:47:47Z Snapshot: 4069925ec9873ba457396077fee9c8be77e9d30342e3266a3eacf47ab5ab0a79 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1828443/explain?concept=fundies%3AOperatingCashFlow&period=2021-01-03&surface=latest&period_type=duration&start=2019-12-30&unit=USD&dimensions= Input fundies:OperatingCashFlow: 46100000 USD (2019-12-30 to 2021-01-03) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1828443/000095017022003035/ocdx-20220102.htm#3238601 Filing: 000095017022003035 The citation records this snapshot. The page link may show a newer release later.	USD 44.1 million Exact value Exact value: 44100000 USD 2019-12-30 – 2021-01-03: 44100000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Ortho Clinical Diagnostics Holdings plc · 2021-01-03 Ortho Clinical Diagnostics Holdings plc (edgar:1828443) Capital Expenditure: 44100000 USD Concept: fundies:CapitalExpenditure Period: 2019-12-30 to 2021-01-03 Values: Latest reported Published: 2026-11-08T17:47:47Z Snapshot: 4069925ec9873ba457396077fee9c8be77e9d30342e3266a3eacf47ab5ab0a79 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1828443/explain?concept=fundies%3ACapitalExpenditure&period=2021-01-03&surface=latest&period_type=duration&start=2019-12-30&unit=USD&dimensions= Input fundies:CapitalExpenditure: 44100000 USD (2019-12-30 to 2021-01-03) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1828443/000095017022003035/ocdx-20220102.htm#3248716 Filing: 000095017022003035 The citation records this snapshot. The page link may show a newer release later.	USD 2 million Calculation and evidence 46100000 − 44100000 USD Exact free cash flow: 2000000 USD 2019-12-30 – 2021-01-03: 46100000 USD · Inspect Operating Cash Flow · Source 2019-12-30 – 2021-01-03: 44100000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Ortho Clinical Diagnostics Holdings plc · 2021-01-03 Ortho Clinical Diagnostics Holdings plc (edgar:1828443) Free cash flow: 2000000 USD Concept: free-cash-flow Period: 2019-12-30 to 2021-01-03 Values: Latest reported Published: 2026-11-08T17:47:47Z Snapshot: 4069925ec9873ba457396077fee9c8be77e9d30342e3266a3eacf47ab5ab0a79 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1828443?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 46100000 USD (2019-12-30 to 2021-01-03) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1828443/000095017022003035/ocdx-20220102.htm#3238601 Filing: 000095017022003035 Input fundies:CapitalExpenditure: 44100000 USD (2019-12-30 to 2021-01-03) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1828443/000095017022003035/ocdx-20220102.htm#3248716 Filing: 000095017022003035 The citation records this snapshot. The page link may show a newer release later.
2022 2021-01-04 – 2022-01-02	−USD 54.3 million Exact value Exact value: -54300000 USD 2021-01-04 – 2022-01-02: -54300000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Ortho Clinical Diagnostics Holdings plc · 2022-01-02 Ortho Clinical Diagnostics Holdings plc (edgar:1828443) Net Income: -54300000 USD Concept: fundies:NetIncome Period: 2021-01-04 to 2022-01-02 Values: Latest reported Published: 2026-11-08T17:47:47Z Snapshot: 4069925ec9873ba457396077fee9c8be77e9d30342e3266a3eacf47ab5ab0a79 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1828443/explain?concept=fundies%3ANetIncome&period=2022-01-02&surface=latest&period_type=duration&start=2021-01-04&unit=USD&dimensions= Input fundies:NetIncome: -54300000 USD (2021-01-04 to 2022-01-02) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1828443/000095017022003035/ocdx-20220102.htm#3416483 Filing: 000095017022003035 The citation records this snapshot. The page link may show a newer release later.	USD 286.6 million Exact value Exact value: 286600000 USD 2021-01-04 – 2022-01-02: 286600000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Ortho Clinical Diagnostics Holdings plc · 2022-01-02 Ortho Clinical Diagnostics Holdings plc (edgar:1828443) Operating Cash Flow: 286600000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-04 to 2022-01-02 Values: Latest reported Published: 2026-11-08T17:47:47Z Snapshot: 4069925ec9873ba457396077fee9c8be77e9d30342e3266a3eacf47ab5ab0a79 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1828443/explain?concept=fundies%3AOperatingCashFlow&period=2022-01-02&surface=latest&period_type=duration&start=2021-01-04&unit=USD&dimensions= Input fundies:OperatingCashFlow: 286600000 USD (2021-01-04 to 2022-01-02) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1828443/000095017022003035/ocdx-20220102.htm#3417426 Filing: 000095017022003035 The citation records this snapshot. The page link may show a newer release later.	USD 58.4 million Exact value Exact value: 58400000 USD 2021-01-04 – 2022-01-02: 58400000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Ortho Clinical Diagnostics Holdings plc · 2022-01-02 Ortho Clinical Diagnostics Holdings plc (edgar:1828443) Capital Expenditure: 58400000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-04 to 2022-01-02 Values: Latest reported Published: 2026-11-08T17:47:47Z Snapshot: 4069925ec9873ba457396077fee9c8be77e9d30342e3266a3eacf47ab5ab0a79 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1828443/explain?concept=fundies%3ACapitalExpenditure&period=2022-01-02&surface=latest&period_type=duration&start=2021-01-04&unit=USD&dimensions= Input fundies:CapitalExpenditure: 58400000 USD (2021-01-04 to 2022-01-02) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1828443/000095017022003035/ocdx-20220102.htm#3246718 Filing: 000095017022003035 The citation records this snapshot. The page link may show a newer release later.	USD 228.2 million Calculation and evidence 286600000 − 58400000 USD Exact free cash flow: 228200000 USD 2021-01-04 – 2022-01-02: 286600000 USD · Inspect Operating Cash Flow · Source 2021-01-04 – 2022-01-02: 58400000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Ortho Clinical Diagnostics Holdings plc · 2022-01-02 Ortho Clinical Diagnostics Holdings plc (edgar:1828443) Free cash flow: 228200000 USD Concept: free-cash-flow Period: 2021-01-04 to 2022-01-02 Values: Latest reported Published: 2026-11-08T17:47:47Z Snapshot: 4069925ec9873ba457396077fee9c8be77e9d30342e3266a3eacf47ab5ab0a79 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1828443?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 286600000 USD (2021-01-04 to 2022-01-02) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1828443/000095017022003035/ocdx-20220102.htm#3417426 Filing: 000095017022003035 Input fundies:CapitalExpenditure: 58400000 USD (2021-01-04 to 2022-01-02) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1828443/000095017022003035/ocdx-20220102.htm#3246718 Filing: 000095017022003035 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

8 filings · 832 latest values · 832 originally reported values

Dataset published 2026-11-08. Source filing dates and reporting periods are shown separately.

Identifiers: 0001828443, 1828443, OCDX, edgar:1828443

Also known as Ortho Clinical Diagnostics Holdings plc, Ortho-Clinical Diagnostics Bermuda Co. Ltd.

Ortho Clinical Diagnostics Holdings plc

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2022 2021-01-04 – 2022-01-02

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation